Pluristem Life Systems Inc. Receives $1.1 Million From Exercise of Warrants

NEW YORK--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB:PLRS), a cell therapy Company dedicated to the commercialization of cell therapy products for a variety of indications, said that as of Friday, March 30, 2007 it has received $1.1 million from the exercise of approximately 15 million warrants at an exercise price of $0.075. This represents exercise of more than 25% of Pluristem’s outstanding listed warrants as of March 30, 2007.